317 results
Page 10 of 16
8-K
EX-99.1
zdiauwv
7 Aug 14
Alimera Sciences Reports Second Quarter 2014 Financial Results
12:00am
8-K
nzahlw5 q6o9l2
7 Aug 14
Alimera Sciences Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
skg5dny
30 Jun 14
Alimera Sciences’ Iluvien® Receives Positive Outcome of Repeat-use Procedure for 10 Additional European Countries
12:00am
8-K
EX-99.1
l2afakx r0fhy
25 Apr 14
Alimera Sciences Secures $35 Million Debt Facility
12:00am
8-K
EX-99.1
4y0zep1
27 Feb 14
Alimera Sciences Reports Fourth Quarter and Full Year 2013 Financial Results
12:00am
8-K
itrnwir f39
27 Feb 14
Alimera Sciences Reports Fourth Quarter and Full Year 2013 Financial Results
12:00am
8-K
EX-99.1
10v735b ezrmr
3 Feb 14
Alimera Sciences Closes $37.5 Million Private Placement
12:00am
8-K
EX-99.1
8e707e
18 Dec 13
Agree Advisory Committee No Longer Necessary
12:00am
8-K
EX-99.1
pz3fvsr
18 Oct 13
Alimera Continues Focus on European Growth
12:00am
8-K
EX-99.1
pgfrra1v
1 Oct 13
U.k.’s Nice Issues Final Appraisal Determination Recommending Alimera’s Iluvien® for Chronic Diabetic Macular Edema
12:00am